Intestinal expression of genes implicated in iron absorption and their regulation by hepcidin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background & aims: Through inhibition of iron absorption and iron mobilization from tissue stores, hepcidin exerts a negative control on iron homeostasis. Hepcidin, in fact, promotes the degradation of ferroportin (Fpn1), the iron exporter molecule expressed on the membrane of hepatocytes and macrophages, thus preventing iron release from cells to plasma. Hepcidin effects on enterocytes, however, are less clear. Aim of the present study was to further investigate the regulation of iron absorption by hepcidin. Methods: The transcriptional response of human duodenal mucosa to hepcidin was investigated using organ cultures of duodenal biopsies perendoscopically collected from healthy controls. Biopsies were cultured for 4 h with or without hepcidin-25 and were then assayed for the expression of iron-related genes. Results: In samples that had not been exposed to hepcidin, correlations were found between the expression of genes involved in iron absorption: . DMT1, . Fpn1, . Dcytb and . HCP1. In . ex vivo experiments hepcidin down-regulated mRNA levels of the iron transporters . Fpn1, and . DMT1, of the ferric reductase . Dcytb, of the ferroxidase . hephaestin, and of the putative heme carrier protein . HCP1. Conclusions: Through the reported transcriptional changes hepcidin can modulate several steps of the iron absorption process, including the reduction of dietary iron by Dcytb, its uptake by enterocytes through DMT1, the mucosal uptake of heme iron by HCP1, and enterocyte iron release to plasma by Fpn1 in conjunction with hephaestin.

Original languageEnglish
JournalClinical Nutrition
DOIs
Publication statusAccepted/In press - Aug 7 2015

Fingerprint

Hepcidins
Iron
Gene Expression
Enterocytes
Dietary Iron
Hemeproteins
Biopsy
Ceruloplasmin
Organ Culture Techniques
Plasma Cells
Heme
Hepatocytes
Carrier Proteins

Keywords

  • Gene expression
  • Heme iron
  • Iron absorption
  • Stat3

ASJC Scopus subject areas

  • Nutrition and Dietetics
  • Critical Care and Intensive Care Medicine

Cite this

@article{f3951a7a797b4710a3729e1f7b28cbfb,
title = "Intestinal expression of genes implicated in iron absorption and their regulation by hepcidin",
abstract = "Background & aims: Through inhibition of iron absorption and iron mobilization from tissue stores, hepcidin exerts a negative control on iron homeostasis. Hepcidin, in fact, promotes the degradation of ferroportin (Fpn1), the iron exporter molecule expressed on the membrane of hepatocytes and macrophages, thus preventing iron release from cells to plasma. Hepcidin effects on enterocytes, however, are less clear. Aim of the present study was to further investigate the regulation of iron absorption by hepcidin. Methods: The transcriptional response of human duodenal mucosa to hepcidin was investigated using organ cultures of duodenal biopsies perendoscopically collected from healthy controls. Biopsies were cultured for 4 h with or without hepcidin-25 and were then assayed for the expression of iron-related genes. Results: In samples that had not been exposed to hepcidin, correlations were found between the expression of genes involved in iron absorption: . DMT1, . Fpn1, . Dcytb and . HCP1. In . ex vivo experiments hepcidin down-regulated mRNA levels of the iron transporters . Fpn1, and . DMT1, of the ferric reductase . Dcytb, of the ferroxidase . hephaestin, and of the putative heme carrier protein . HCP1. Conclusions: Through the reported transcriptional changes hepcidin can modulate several steps of the iron absorption process, including the reduction of dietary iron by Dcytb, its uptake by enterocytes through DMT1, the mucosal uptake of heme iron by HCP1, and enterocyte iron release to plasma by Fpn1 in conjunction with hephaestin.",
keywords = "Gene expression, Heme iron, Iron absorption, Stat3",
author = "Gaetano Bergamaschi and {Di Sabatino}, Antonio and Alessandra Pasini and Cristina Ubezio and Filippo Costanzo and Davide Grataroli and Michela Masotti and Costanza Alvisi and Corazza, {Gino R.}",
year = "2015",
month = "8",
day = "7",
doi = "10.1016/j.clnu.2016.09.021",
language = "English",
journal = "Clinical Nutrition",
issn = "0261-5614",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Intestinal expression of genes implicated in iron absorption and their regulation by hepcidin

AU - Bergamaschi, Gaetano

AU - Di Sabatino, Antonio

AU - Pasini, Alessandra

AU - Ubezio, Cristina

AU - Costanzo, Filippo

AU - Grataroli, Davide

AU - Masotti, Michela

AU - Alvisi, Costanza

AU - Corazza, Gino R.

PY - 2015/8/7

Y1 - 2015/8/7

N2 - Background & aims: Through inhibition of iron absorption and iron mobilization from tissue stores, hepcidin exerts a negative control on iron homeostasis. Hepcidin, in fact, promotes the degradation of ferroportin (Fpn1), the iron exporter molecule expressed on the membrane of hepatocytes and macrophages, thus preventing iron release from cells to plasma. Hepcidin effects on enterocytes, however, are less clear. Aim of the present study was to further investigate the regulation of iron absorption by hepcidin. Methods: The transcriptional response of human duodenal mucosa to hepcidin was investigated using organ cultures of duodenal biopsies perendoscopically collected from healthy controls. Biopsies were cultured for 4 h with or without hepcidin-25 and were then assayed for the expression of iron-related genes. Results: In samples that had not been exposed to hepcidin, correlations were found between the expression of genes involved in iron absorption: . DMT1, . Fpn1, . Dcytb and . HCP1. In . ex vivo experiments hepcidin down-regulated mRNA levels of the iron transporters . Fpn1, and . DMT1, of the ferric reductase . Dcytb, of the ferroxidase . hephaestin, and of the putative heme carrier protein . HCP1. Conclusions: Through the reported transcriptional changes hepcidin can modulate several steps of the iron absorption process, including the reduction of dietary iron by Dcytb, its uptake by enterocytes through DMT1, the mucosal uptake of heme iron by HCP1, and enterocyte iron release to plasma by Fpn1 in conjunction with hephaestin.

AB - Background & aims: Through inhibition of iron absorption and iron mobilization from tissue stores, hepcidin exerts a negative control on iron homeostasis. Hepcidin, in fact, promotes the degradation of ferroportin (Fpn1), the iron exporter molecule expressed on the membrane of hepatocytes and macrophages, thus preventing iron release from cells to plasma. Hepcidin effects on enterocytes, however, are less clear. Aim of the present study was to further investigate the regulation of iron absorption by hepcidin. Methods: The transcriptional response of human duodenal mucosa to hepcidin was investigated using organ cultures of duodenal biopsies perendoscopically collected from healthy controls. Biopsies were cultured for 4 h with or without hepcidin-25 and were then assayed for the expression of iron-related genes. Results: In samples that had not been exposed to hepcidin, correlations were found between the expression of genes involved in iron absorption: . DMT1, . Fpn1, . Dcytb and . HCP1. In . ex vivo experiments hepcidin down-regulated mRNA levels of the iron transporters . Fpn1, and . DMT1, of the ferric reductase . Dcytb, of the ferroxidase . hephaestin, and of the putative heme carrier protein . HCP1. Conclusions: Through the reported transcriptional changes hepcidin can modulate several steps of the iron absorption process, including the reduction of dietary iron by Dcytb, its uptake by enterocytes through DMT1, the mucosal uptake of heme iron by HCP1, and enterocyte iron release to plasma by Fpn1 in conjunction with hephaestin.

KW - Gene expression

KW - Heme iron

KW - Iron absorption

KW - Stat3

UR - http://www.scopus.com/inward/record.url?scp=84992184123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992184123&partnerID=8YFLogxK

U2 - 10.1016/j.clnu.2016.09.021

DO - 10.1016/j.clnu.2016.09.021

M3 - Article

AN - SCOPUS:84992184123

JO - Clinical Nutrition

JF - Clinical Nutrition

SN - 0261-5614

ER -